BCMA-specific CAR-expressing T Lymphocytes is a BCMA targeted CAR T Cell therapy being developed at the Fred Hutchinson Cancer Research Center.
|Generic Name||BCMA-Specific CAR-Expressing T Lymphocytes|
View all active clinical trials around the US.
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
December 07, 2019
There are no resources, links or videos to display for this treatment.